AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Pandrea, I Descamps, D Collin, G Robertson, DL Damond, F Dimitrienco, V Gheorghita, S Pecec, M Simon, F Brun-Vezinet, F Apetrei, C
Citation: I. Pandrea et al., HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova, AIDS RES H, 17(13), 2001, pp. 1297-1304

Authors: Simon, F Souquiere, S Damond, F Kfutwah, A Makuwa, M Leroy, E Rouquet, P Berthier, JL Rigoulet, J Lecu, A Telfer, PT Pandrea, I Plantier, JC Barre-Sinoussi, F Roques, P Muller-Trutwin, MC Apetrei, C
Citation: F. Simon et al., Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses, AIDS RES H, 17(10), 2001, pp. 937-952

Authors: Girard, PM Schneider, V Dehee, A Mariot, P Jacomet, C Delphin, N Damond, F Carcelain, G Autran, B Saimot, AG Nicolas, JC Rozenbaum, W
Citation: Pm. Girard et al., Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection, AIDS, 15(2), 2001, pp. 275-277

Authors: Damond, F Descamps, D Farfara, I Telles, JN Puyeo, S Campa, P Lepretre, A Matheron, S Brun-Vezinet, F Simon, F
Citation: F. Damond et al., Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR, J CLIN MICR, 39(12), 2001, pp. 4264-4268

Authors: Plantier, JC Damond, F Souquieres, S Brun-Vezinet, F Simon, F Barin, F
Citation: Jc. Plantier et al., V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant, J CLIN MICR, 39(10), 2001, pp. 3803-3807

Authors: Damond, F Apetrei, C Robertson, DL Souquiere, S Lepretre, A Matheron, S Plantier, JC Brun-Vezinet, F Simon, F
Citation: F. Damond et al., Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in France, VIROLOGY, 280(1), 2001, pp. 19-30

Authors: Levacher, M Bouscarat, F Landman, R Chau, F Damond, F Gaudebout, C Mathez, D Leibowitch, J Saimot, AG Sinet, M
Citation: M. Levacher et al., Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir, AIDS RES H, 16(17), 2000, pp. 1869-1875

Authors: Couturier, E Damond, F Roques, P Fleury, H Barin, F Brunet, JB Brun-Vezinet, F Simon, F
Citation: E. Couturier et al., HIV-1 diversity in France, 1996-1998, AIDS, 14(3), 2000, pp. 289-296

Authors: Plantier, JC Damond, F Lasky, M Sankale, JL Apetrei, C Peeters, M Buzelay, L M'Boup, S Kanki, P Delaporte, E Simon, F Barin, F
Citation: Jc. Plantier et al., V3 serotyping of HIV-1 infection: Correlation with genotyping and limitations, J ACQ IMM D, 20(5), 1999, pp. 432-441

Authors: Roques, P Menu, E Narwa, R Scarlatti, G Tresoldi, E Damond, F Mauclere, P Dormont, D Chaouat, G Simon, F Barre-Sinoussi, F
Citation: P. Roques et al., An unusual HIV type 1 env sequence embedded in a mosaic virus from Cameroon: Identification of a new env clade, AIDS RES H, 15(17), 1999, pp. 1585-1589

Authors: Carcelain, G Blanc, C Leibowitch, J Mariot, P Mathez, D Schneider, V Saimot, AG Damond, F Simon, F Debre, P Autran, B Girard, PM
Citation: G. Carcelain et al., T cell changes after combined nucleoside analogue therapy in HIV primary infection, AIDS, 13(9), 1999, pp. 1077-1081

Authors: Damond, F Apetrei, C Descamps, D Brun-Vezinet, F Simon, F
Citation: F. Damond et al., HIV-1 subtypes and plasma RNA quantification, AIDS, 13(2), 1999, pp. 286-288

Authors: Brun-Vezinet, F Damond, F Simon, F
Citation: F. Brun-vezinet et al., Variability of human immunodeficiency viruses type 1., B S PATH EX, 92(4), 1999, pp. 261-263
Risultati: 1-13 |